Subscribe
View Digital Edition
At the Third Annual Conference of the Association for Value-Based Cancer Care, James Lang, PharmD, Vice President of Pharmacy Services at BlueCross BlueShield of Michigan (BCBSM), shared his company’s approach to new managed market challenges.
Tobacco use among patients with cancer is an important, but often overlooked, issue that requires intervention by oncology practices.
On October 1, 2014, the United States will adopt the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System (ICD-10-CM/PCS).
Initial survey results from the Association of Community Cancer Centers (ACCC) show that nearly 60% of the respondents say they’ve made significant changes in how they run their practices just in the past 3 months.
A majority of oncologists, patients with cancer, and members of the general public support cutting healthcare costs by refusing to pay for drugs that do not improve survival rates or quality of life. This is according to the results of a new study that were presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago.
Researchers from University Hospitals Case Medical Center (UHCMC)’s Seidman Can­cer Center presented findings from 2 studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the widespread inconsistencies that currently limit secure sharing of information between providers, patients, and researchers.
The issue of cost in clinical decision-making is increasingly becoming necessary in the face of growing healthcare costs, limited resources, and often limited access to care.
The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of lung cancer.
Because of failed debt negotiation talks back in 2011, on April 1, 2013, an automatic 2% reduction in payment took place across the board on all claims submitted for Medicare reimbursement.
Page 1 of 2
Results 1 - 10 of 13
  • American Health and Drug Benefits
  • Association for Value Based Cancer Care
  • Lynx CME
  • Oncology Practice Management
  • Rheumatology Practice Management

Search